Items Tagged ‘lymphoma’
July 18, 2019
Targeting therapy to each patient’s unique cancer
By Sharon Rosen 
Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support for Precision […]
Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma
May 29, 2019
By Sharon Rosen
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma
July 23, 2018
Meet Saad Kenderian: Using the body to recognize and attack cancer
For as long as he can remember, Saad Kenderian, M.B., Ch.B., wanted to be a physician. Nothing could blunt his resolve –not even when improvised explosive devices, bombs and trappings of war put the medical school in his native Baghdad, Iraq, on a brief hiatus. It is with that same determination he leads Mayo Clinic’s […]
Tags: #CAR T-cell therapy, #leukemia, Dr. Saad Kenderian, immunotherapy, lymphoma, mayo clinic, Mayo Clinic Center for Individualized Medicine
March 27, 2018
Putting the precision in precision medicine care for non-Hodgkin’s lymphoma
By Sharon Rosen
Each year, more than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma. While the likelihood of developing the disease increases with age, men and women in all age groups and from many ethnic backgrounds can develop the disease, which can start in many areas of […]
Tags: #blood test, #diffuse large B cell lymphoma, #Dr. Grzegorz Nowakowski, #Dr. Lisa Rimsza, #medical reearch, #Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, DNA, DNA Sequencing, genetic test, Genetics
December 21, 2016
Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients
By Sharon Rosen
Article by Colette Gallagher, Public Affairs More than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma each year. Mayo Clinic is the first site in the country to offer a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell […]
Tags: #diffuse large B cell lymphoma, #Lymph2Cx test, #Mayo Clinic Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, lymphoma, mayo clinic, medical research, Precision Medicine
February 25, 2014
Faster Cancer Discoveries by Developing Speedier Tumor Analysis Software
Researchers at Mayo Clinic have created a new key to unlocking secrets of the human genome. The Binary Indexing Mapping Algorithm, version 3 (BIMA V3) is a freely available computer algorithm that identifies alterations in tumor genomes up to 20 times faster and with 25 percent greater accuracy than other popular genomic alignment programs. BIMA […]
Tags: BIMA, Binary Indexing Mapping Algorithm, Biomarker Discovery Program, Burrows-Wheeler Aligner, cancer, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics, individualized medicine
January 14, 2014
Pursuing Future Ventures in Biomarker Discovery
By Sam Smith
Five business students from around the state have immersed themselves in our Biomarker Discovery Program where they are conducting commercial assessments of Mayo Clinic discoveries in cancer diagnostics. These students, who work with the Center for Individualized Medicine and Mayo Clinic Ventures, conduct a semester-long evaluation of molecular discoveries that could help oncologists better diagnose […]
Tags: biomarker, Biomarker Discovery, biomarkers, cancer, Cancer Research, individualized medicine, lymphoma, mayo clinic, Mayo Clinic Ventures, oncology, personalized care, personalized medicine